Competitive signals emerge across trials, publications, regulatory filings, and market events. CI Lens continuously monitors these sources, detecting meaningful shifts that impact strategic planning and portfolio management.
CI Lens is an intelligence layer for strategic planning, market access, and portfolio decisions built on traceable evidence, not black-box predictions. Every insight is grounded in competitor pipelines, trial data, publications, and market signals with full regulatory readiness. Not analytics alone. Not generic AI for competitive intelligence. Intelligence you can audit, explain, and trust when strategic decisions and billion-dollar investments are on the line.
Fully Traceable
Works With Any AI Model
Grounded in Verified Knowledge
No Vector DBs
7 Patented Innovations
Deployed In Your Environment
Standard Infrastructure


Fully Traceable
Works With Any AI Model
Grounded in Verified Knowledge
No Vector DBs
7 Patented Innovations
Deployed In Your Environment
Standard Infrastructure


Manual CI is incompatible with strategic decision-making and portfolio management. When leadership teams demand evidence, market positioning is at stake, and decisions involve hundreds of millions in investment, "the CI report said so" is not acceptable.
CI Lens is a purpose-built intelligence solution that synthesises competitive signals across pipelines, trials, publications, and markets into defensible, traceable insights for strategic leadership teams. Built on the Knowledge & AI Memory Platform, CI Lens transforms fragmented competitive information into a structured competitive knowledge graph that captures
CI Lens operates as a continuous intelligence system, not a one-time analysis tool. The platform follows a structured, governed workflow:
Automated ingestion from pipelines, trials, publications, regulatory filings, and market reports with version tracking.
Extract and normalise competitive assets, indications, mechanisms, stages, and sponsors into comparable entities.
Identify competitive signals across trials, publications, partnerships, and regulatory events with historical context.
Produce evidence-backed intelligence with inline citations linking every claim to verified sources.
Monitor for new competitor developments, regulatory updates, published results, keeping intelligence current and relevant.
Map ongoing, completed, and planned competitor pipelines across indications, mechanisms, development stage, and sponsor with real-time intelligence you can verify.
Deep analysis of indication/mechanism overlap, endpoint selection, trial design strategies, and competitive positioning with comparative benchmarking.
Detect protocol amendments, new trial initiations, partnership announcements, regulatory filings, and market shifts with contextual analysis across the ecosystem.
Consolidate efficacy results, safety signals, and patient outcomes from multiple trials with unified citations cross-referencing.
Every insight is linked directly to competitor disclosures, trial registries, protocol documents, and publications ready for regulatory review and audit documentation.
Expert review workflows, approval gates, and version control ensure that analytics meet regulatory and organisational standards.
Private by design. Speaks your language. Proven at scale
Track competing therapeutic approaches, mechanisms under investigation, and regulatory pathway differences with trial precedents.
Understand global competitive recruitment environments, regional partners, and regulatory pathway differences.
Monitor competitor sponsors (biotech, pharma, and academic activity). Assess pipeline transitions and anticipated phase completions.
Evaluate endpoint selection patterns, protocol choices, and inclusion criteria to avoid redundant strategies and accelerate design.
Competitive signals emerge across trials, publications, regulatory filings, and market events. CI Lens continuously monitors these sources, detecting meaningful shifts that impact strategic planning and portfolio management.
Detect new trial initiations, protocol modifications, recruitment pauses, and early termination signals across your competitive landscape.
Monitor peer-reviewed publications, conference abstracts, and investigator presentations for efficacy insights and safety signals.
Track regulatory filings, approval decisions, label expansions, and partnership announcements with timeline context.
Identify emerging competitors, discontinued programs, and strategic pivots that reshape the competitive environment.
CI Lens transforms life sciences market intelligence from static reports into continuous intelligence. Track competitor pipelines, regulatory milestones, and strategic moves with evidence chains linking every insight to original sources—and intelligence that auto-updates as the competitive landscape shifts, keeping your strategy grounded in current reality.
EVIDENCE CHAIN TRACEABILITY
SEC Filing
Clinical Trial Registration
Scientific Publication
Analysis Layer & Insight
Synthesizing competitor M&A strategy from 12 verified sources...
Strategic Decision
CI Lens serves teams across the strategic development lifecycle who need defensible intelligence to inform strategy, positioning, and portfolio decisions.
Assess competitive positioning and market dynamics. Analyze pipeline activity, identify emerging threats, and detect strategic opportunities using intelligence that informs executive decision-making.
Evaluate payer decisions with confidence. Evaluate competitive labelling, endpoint selection, and market positioning opportunities using intelligence tools grounded in real trial data.
Support evidence generation strategy. Synthesise trial outcomes and track commercial pipeline insights backed by verifiable sources for publications and presentations.
Assess partnerships and market positioning. Analyse sponsor activity, evaluate pipeline gaps, and benchmark programs with intelligence that informs funding and M&A decisions.
Make portfolio decisions with audit-ready evidence. Every strategic recommendation is backed by a supporting competitive rationale linked to verifiable trial evidence for review and documentation.
Align stakeholders with shared intelligence. One source of truth for competitive landscape, pipeline activity, and evidence synthesis accessible across functions.
Competitor tracking tools provide pipeline lists. Analytics dashboards visualize trends. CI Lens delivers pharma competitive intelligence, structured knowledge with traceable reasoning that enables defensible portfolio decisions under investor and board scrutiny. The difference between competitor data vs strategic intelligence is fundamental to how pharma leadership operates.
Capability Matrix
Cross-tier feature evaluation
Flat Data Access
Pipeline Databases
Visualization Layer
Market Dashboards
Intelligence Layer
CI Lens
No Limitations
Full Cognitive Synthesis
Knolens gave us a living evidence base across trials, publications, and HTA data. Our teams can now move from research to decision in hours instead of weeks.
Head of Global Market Access, Big Pharma
Finally an AI platform we can trust. Every insight is traceable back to the source evidence.
Director, HEOR & Evidence Strategy
Knolens transformed how our analysts work. Less time gathering information, more time delivering insights to clients.
Partner, Life Sciences Strategy Consulting Firm
We used to build analysis manually across dozens of sources. Knolens gives us a continuously updated intelligence layer.
Managing Director, Pharma Consulting Practice
Address
One Research Ct, Suite 450
Rockville, MD 20850
For General Inquiry
info@pienomial.com